[51, 52] Intriguingly, EP300, a transcriptional co-activator of CREB1, is frequently mutated, lost or underexpressed in numerous types of cancer, such as gastric cancer, colon cancer, and breast cancer. This evidence concerns the gene CREB1 and malignant colon neoplasm.